Rezolute, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
RZLT Nasdaq 2830 www.rezolutebio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Rezolute, Inc.

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism - Jan 7th, 2026 5:00 am
Rezolute’s Phase 3 sunRIZE Study for Ersodetug Fails to Meet Primary and Secondary Endpoints Despite Analyst Backing - Dec 31st, 2025 9:12 am
Insiders Made Their Bets in 2025—These Were the Top 5 Stocks They Bought - Dec 30th, 2025 2:39 pm
Chief Financial Officer of Rezolute Daron Evans Buys 21% More Shares - Dec 18th, 2025 4:07 am
RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know - Dec 17th, 2025 7:47 am
Down 81.8% in 4 Weeks, Here's Why Rezolute (RZLT) Looks Ripe for a Turnaround - Dec 15th, 2025 7:35 am
Rezolute (RZLT) Is Down 82.7% After Phase 3 sunRIZE Failure in Congenital Hyperinsulinism Trial - Dec 14th, 2025 8:08 pm
Rezolute stock crashes after sole pipeline candidate fails Phase III - Dec 12th, 2025 9:52 am
Praxis tees up another approval filing; Geron turns to layoffs - Dec 12th, 2025 3:18 am
Xoma Crumbles And Partner Rezolute Collapses On Failed Insulin Disease Drug - Dec 11th, 2025 4:41 pm
Rezolute (RZLT): Assessing Valuation After a Year of Strong Share Price Gains - Dec 11th, 2025 1:10 pm
Top Midday Decliners - Dec 11th, 2025 12:19 pm
Top Midday Stories: Oracle Shares Tumble After Revenue Miss; Lilly's Next-Gen Weight-Loss Drug Hits Primary Endpoints - Dec 11th, 2025 9:36 am
BC-Most Active Stocks - Dec 11th, 2025 8:30 am
Rezolute Says Phase 3 Ersodetug Trial Fails to Meet Primary and Key Secondary Endpoints - Dec 11th, 2025 5:55 am
Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism - Dec 11th, 2025 5:00 am
How Much Upside is Left in Rezolute (RZLT)? Wall Street Analysts Think 56.58% - Dec 1st, 2025 7:55 am
KLKB1 Inhibitors Market to Reach New Heights by 2034 Owing to the Launch of Novel Therapies | DelveInsight - Nov 19th, 2025 3:31 pm
All You Need to Know About Rezolute (RZLT) Rating Upgrade to Buy - Nov 12th, 2025 10:00 am
Can Rezolute (RZLT) Climb 49.4% to Reach the Level Wall Street Analysts Expect? - Nov 12th, 2025 7:55 am